Intervention

minocycline

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 7 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials7

Recruiting0

Common conditions8

Lead sponsors shown7

Clinical trials

7 shown

Minocycline for SchizophreniaNCT01809158 · 2013-04-01

COMPLETED

Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective DisorderNCT01320982 · 2011-03-01

UNKNOWN

The Study of Minocycline for Negative and Cognitive Symptoms in SchizophreniaNCT01493622 · 2010-06-01

COMPLETED

Minocycline for HIV+ Cognitive Impairment in UgandaNCT00855062 · 2008-04-01

TERMINATED

Minocycline to Prevent Acute Kidney Injury After Cardiac SurgeryNCT00556491 · 2007-12-01

COMPLETED

National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection TrialNCT00063193 · 2003-05-01

COMPLETED

Evaluation of the Utility of Minocycline as an Anti-Inflammatory Agent in the Treatment of AsthmaNCT00456677 · 1996-06-01

COMPLETED

Common conditions

Schizophrenia3 Acute Kidney Insufficiency1 Asthma1 HIV Infections1 HIV-associated Cognitive Impairment1 Kidney Failure, Acute1 Parkinson's Disease1 Schizoaffective Disorder1

Leading sponsors

Addis Ababa University 1 Central South University 1 Johns Hopkins University 1 Sheba Medical Center 1 State University of New York - Downstate Medical Center 1 Tarek M. El-Achkar 1 University of Rochester 1

Trial status mix

COMPLETED5

TERMINATED1

UNKNOWN1

Phase mix

PHASE23

PHASE42

NA1

PHASE11

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.